Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...

Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...

Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo Nordisk.

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...

Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...

A trial assessing a new daily pill for weight loss has shown that people taking the drug can shed kilos in weeks, potentially ...

EUROPEAN shares logged their biggest daily rise in over two weeks on Thursday, boosted by financial stocks as investors ...

Kelley Mack, who played the Hilltop Colony resident Addy on the ninth season of AMC’s The Walking Dead in 2018-19, died ...

President Trump’s latest tariff threat has targeted a sector that’s already hobbled.